Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Pelegrin

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2015
AIM2 and NLRC4 inflammasomes contribute with ASC to acute brain injury independently of NLRP3Adam Denes, Graham Coutts, Nikolett Lénárt, et al.
Nature Communications|December 7, 2018
NLRP3 lacking the leucine-rich repeat domain can be fully activated via the canonical inflammasome pathwayIva Hafner-Bratkovič, Petra Sušjan, Duško Lainšček, et al.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|July 22, 2021
Impact of Immune Response in Short-term and Long-term Outcomes After Minimally Invasive Surgery for Colorectal Liver Metastases: Results From a Randomized StudyVictor Lopez-Lopez, Alvaro Gómez Ruiz, Pablo Pelegrin, et al.
The Australasian Journal of Dermatology|February 17, 2023
Early-onset recurrent panniculitis as a phenotype of NLRC4-associated autoinflammatory syndrome: Characterization of pathogenicity of the p.Ser445Pro NLRC4 variantJavier Gil-Lianes, Giuseppe Gariup, Pilar Iranzo-Fernández, et al.
Cell Reports|September 28, 2024
Ornithine lipid is a partial TLR4 agonist and NLRP3 activatorMalvina Pizzuto, Laura Hurtado-Navarro, Cristina Molina-Lopez, et al.
The Journal of Cell Biology|July 4, 2023
ASC oligomer favors caspase-1CARD domain recruitment after intracellular potassium effluxFátima Martín-Sánchez, Vincent Compan, Alejandro Peñín-Franch, et al.
Cell Reports|February 26, 2025
Gasdermin D mediates a fast transient release of ATP after NLRP3 inflammasome activation before ninjurin 1-induced lytic cell deathJulieta Schachter, Adriana Guijarro, Diego Angosto-Bazarra, et al.
Frontiers in Immunology|June 6, 2022
Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease SeverityJulio García-Villalba, Laura Hurtado-Navarro, Alejandro Peñín-Franch, et al.
Cellular and Molecular Life Sciences : CMLS|May 8, 2019
Saturation of acyl chains converts cardiolipin from an antagonist to an activator of Toll-like receptor-4Malvina Pizzuto, Caroline Lonez, Alberto Baroja-Mazo, et al.
Cellular and Molecular Life Sciences : CMLS|July 25, 2019
Correction to: Saturation of acyl chains converts cardiolipin from an antagonist to an activator of Toll-like receptor-4Malvina Pizzuto, Caroline Lonez, Alberto Baroja-Mazo, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2015
AIM2 and NLRC4 inflammasomes contribute with ASC to acute brain injury independently of NLRP3Adam Denes, Graham Coutts, Nikolett Lénárt, et al.
Nature Communications|December 7, 2018
NLRP3 lacking the leucine-rich repeat domain can be fully activated via the canonical inflammasome pathwayIva Hafner-Bratkovič, Petra Sušjan, Duško Lainšček, et al.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|July 22, 2021
Impact of Immune Response in Short-term and Long-term Outcomes After Minimally Invasive Surgery for Colorectal Liver Metastases: Results From a Randomized StudyVictor Lopez-Lopez, Alvaro Gómez Ruiz, Pablo Pelegrin, et al.
The Australasian Journal of Dermatology|February 17, 2023
Early-onset recurrent panniculitis as a phenotype of NLRC4-associated autoinflammatory syndrome: Characterization of pathogenicity of the p.Ser445Pro NLRC4 variantJavier Gil-Lianes, Giuseppe Gariup, Pilar Iranzo-Fernández, et al.
Cell Reports|September 28, 2024
Ornithine lipid is a partial TLR4 agonist and NLRP3 activatorMalvina Pizzuto, Laura Hurtado-Navarro, Cristina Molina-Lopez, et al.
The Journal of Cell Biology|July 4, 2023
ASC oligomer favors caspase-1CARD domain recruitment after intracellular potassium effluxFátima Martín-Sánchez, Vincent Compan, Alejandro Peñín-Franch, et al.
Cell Reports|February 26, 2025
Gasdermin D mediates a fast transient release of ATP after NLRP3 inflammasome activation before ninjurin 1-induced lytic cell deathJulieta Schachter, Adriana Guijarro, Diego Angosto-Bazarra, et al.
Frontiers in Immunology|June 6, 2022
Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease SeverityJulio García-Villalba, Laura Hurtado-Navarro, Alejandro Peñín-Franch, et al.
Cellular and Molecular Life Sciences : CMLS|May 8, 2019
Saturation of acyl chains converts cardiolipin from an antagonist to an activator of Toll-like receptor-4Malvina Pizzuto, Caroline Lonez, Alberto Baroja-Mazo, et al.
Cellular and Molecular Life Sciences : CMLS|July 25, 2019
Correction to: Saturation of acyl chains converts cardiolipin from an antagonist to an activator of Toll-like receptor-4Malvina Pizzuto, Caroline Lonez, Alberto Baroja-Mazo, et al.
Pageof 6